ZA200500719B - The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis. - Google Patents

The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.

Info

Publication number
ZA200500719B
ZA200500719B ZA200500719A ZA200500719A ZA200500719B ZA 200500719 B ZA200500719 B ZA 200500719B ZA 200500719 A ZA200500719 A ZA 200500719A ZA 200500719 A ZA200500719 A ZA 200500719A ZA 200500719 B ZA200500719 B ZA 200500719B
Authority
ZA
South Africa
Prior art keywords
ciclesonide
combination
antihitamines
treatment
allergic rhinitis
Prior art date
Application number
ZA200500719A
Other languages
English (en)
Inventor
Degenhard Marx
Helgert Mueller
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of ZA200500719B publication Critical patent/ZA200500719B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200500719A 2002-08-30 2005-01-25 The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis. ZA200500719B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02019406 2002-08-30

Publications (1)

Publication Number Publication Date
ZA200500719B true ZA200500719B (en) 2006-02-22

Family

ID=31970274

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500719A ZA200500719B (en) 2002-08-30 2005-01-25 The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.

Country Status (21)

Country Link
US (2) US7879832B2 (es)
EP (2) EP1545548B1 (es)
JP (2) JP4746318B2 (es)
KR (1) KR101067795B1 (es)
CN (1) CN1674916A (es)
AT (1) ATE472329T1 (es)
AU (1) AU2003273396B2 (es)
BR (2) BR0313611A (es)
CA (1) CA2495830C (es)
DE (1) DE60333205D1 (es)
DK (1) DK1545548T3 (es)
ES (2) ES2393864T3 (es)
IL (1) IL166483A (es)
MX (1) MXPA05001885A (es)
NO (1) NO335400B1 (es)
NZ (1) NZ538954A (es)
PL (1) PL373433A1 (es)
PT (1) PT1545548E (es)
SI (1) SI1545548T1 (es)
WO (1) WO2004019955A1 (es)
ZA (1) ZA200500719B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
DK1572217T3 (da) * 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
WO2004110460A1 (en) * 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
NZ555501A (en) 2004-11-24 2010-01-29 Medpointe Healthcare Inc Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
KR100878698B1 (ko) * 2007-04-05 2009-01-13 한미약품 주식회사 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
EP2624836B1 (en) * 2010-10-06 2015-09-23 Bausch & Lomb Incorporated Bepotastine compositions
JP5683719B2 (ja) * 2011-01-04 2015-03-11 イスタ・ファーマシューティカルズ・インコーポレイテッドＩｓｔａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． ベポタスチン組成物
CA2906008C (en) 2013-03-13 2019-07-09 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (es) 1963-04-24
US3813384A (en) 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en) 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
ATE84968T1 (de) 1987-11-13 1993-02-15 Asta Medica Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
EP0701565B1 (de) 1993-04-02 1998-10-28 Byk Gulden Lomberg Chemische Fabrik GmbH Neue prednisolonderivate
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
AU6290396A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
WO1997001337A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
JPH11511758A (ja) 1996-06-04 1999-10-12 ザ、プロクター、エンド、ギャンブル、カンパニー 鼻腔用ステロイドと抗ヒスタミン剤を含む鼻腔内噴霧薬
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
IL131492A0 (en) 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6297227B1 (en) 1998-09-10 2001-10-02 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CA2356177A1 (en) 1999-10-20 2001-04-26 Kazuya Takanashi Aqueous pharmaceutical compositions
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AU772406B2 (en) 1999-11-18 2004-04-29 Alcon Inc. Use of H1 antagonist and a safe steroid to treat eye conditions
US20040097486A1 (en) 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
CN1599625A (zh) 2001-12-05 2005-03-23 爱尔康公司 H1拮抗剂和安全类固醇治疗鼻炎的用途
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2504200A1 (en) 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis

Also Published As

Publication number Publication date
CA2495830A1 (en) 2004-03-11
SI1545548T1 (sl) 2010-11-30
NO20051521L (no) 2005-03-22
MXPA05001885A (es) 2005-06-03
KR20050058400A (ko) 2005-06-16
CN1674916A (zh) 2005-09-28
IL166483A0 (en) 2006-01-15
DE60333205D1 (de) 2010-08-12
KR101067795B1 (ko) 2011-09-27
ES2348034T3 (es) 2010-11-29
EP2295062B1 (en) 2012-08-29
US20050245493A1 (en) 2005-11-03
US20110092471A1 (en) 2011-04-21
NO20051521D0 (no) 2005-03-22
NZ538954A (en) 2007-04-27
PT1545548E (pt) 2010-09-02
JP2005539044A (ja) 2005-12-22
CA2495830C (en) 2012-08-21
BRPI0313611B1 (pt) 2018-03-06
ATE472329T1 (de) 2010-07-15
AU2003273396B2 (en) 2008-12-11
JP2011021043A (ja) 2011-02-03
NO335400B1 (no) 2014-12-08
DK1545548T3 (da) 2010-09-27
EP1545548A1 (en) 2005-06-29
JP4746318B2 (ja) 2011-08-10
IL166483A (en) 2013-11-28
WO2004019955A1 (en) 2004-03-11
AU2003273396A1 (en) 2004-03-19
EP2295062A1 (en) 2011-03-16
EP1545548B1 (en) 2010-06-30
BR0313611A (pt) 2005-06-21
ES2393864T3 (es) 2012-12-28
US8486923B2 (en) 2013-07-16
PL373433A1 (en) 2005-08-22
US7879832B2 (en) 2011-02-01

Similar Documents

Publication Publication Date Title
ZA200500719B (en) The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.
IL176393A0 (en) Patterned laser treatment of the retina
AU2003220553A1 (en) Combination therapy for the treatment of conditions with pathogenic inflammatory components
EE05417B1 (et) Epotilooni analoogide ja kemoterapeutikumide kombinatsiooni kasutamine teraapias
HK1092367A1 (en) Combination therapy for the treatment of ocular neovascular disorders
ATE414514T1 (de) Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
EP1592435A4 (en) EYE FORMULATION FOR THE PREVENTION AND TREATMENT OF EYE DRESS
EP1534074A4 (en) POLYTHERAPY FOR THE TREATMENT OF OBESITY
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
GB0213869D0 (en) The treatment of pain
DE60326190D1 (de) des Körpers
HK1083767A1 (en) Combined use of a fibrate and orlistat for the treatment of obesity
ATE491442T1 (de) 1-phenyl-2- dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
GB2388027B (en) Use of palatinose for the treatment of mental stress
PL372534A1 (en) The treatment of pain with ifendropil
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
TNSN05154A1 (en) Use of levocetirizine for the treatment of persistent allergic rhinitis
DE60304678D1 (de) Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose
GB0216220D0 (en) The treatment of emesis nausea and other disorders
SI1392292T1 (sl) Piranoindazoli in njihova uporaba pri zdravljenjuglavkoma